Aspiriant Capital Appreciation Fund (CIK 1830974) is an SEC-registered fund company and $143.4M in net assets as of 2026-03-31.
| Series | Net assets |
|---|---|
| Aspiriant Capital Appreciation Fund | $143.4M |
| Holding | Value |
|---|---|
| RA Capital Healthcare Fund, L.P. | $15.8M |
| Stripes, LP | $14.6M |
| GMO Quality | $14.1M |
| DFA Global Equity Portfolio | $12.0M |
| AQR Delphi Long-Short Equity Fund, L.P. | $11.4M |
| The Children's Investment Fund, L.P. | $11.2M |
| American Funds New Perspective Fund | $10.6M |
| Coatue Qualified Partners, LP | $9.7M |
| Oaktree Opportunities Fund, L.P. | $9.5M |
| Viking Global Opportunities LP | $8.8M |
| Blackstone Life Sciences L.P. | $6.2M |
| New Mountain Partners, L.P. | $4.5M |
| iShares MSCI ACWI ETF | $4.3M |
| RA Capital Nexus Fund, L.P. | $3.3M |
| Revolution Ventures, LP | $2.3M |